EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression

Ramiro A Ramirez-Valdez, Faezzah Baharom, Ahad Khalilnezhad, Sloane C Fussell, Dalton J Hermans, Alexander M Schrager, Kennedy K S Tobin, Geoffrey M Lynn, Shabnam Khalilnezhad, Florent Ginhoux, Benoit J Van den Eynde, Carol Sze Ki Leung und 2 weitere

Cell Reports · 2023-06 · 42 (6) · 112599

DOI: 10.1016/j.celrep.2023.112599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-06. Verfasst von Ramiro A Ramirez-Valdez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA; Ludwig Institute for…. Hauptthemen laut MEDLINE: Vaccination, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinationCD8-Positive T-LymphocytesHumansMiceAnimalsAdaptive ImmunityGenetic VectorsAdjuvants, Immunologic

Stichwörter der Autor:innen

CP: CancerCP: Immunologycancer vaccineheterologous prime boost

Substanzen

Adjuvants, Immunologic

Autor:innen und Institutionen

  • Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxfor…
  • Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.
  • Singapore Immunology Network, A(∗)STAR, Singapore, Singapore; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Vaccitech North America, Baltimore, MD, USA.
  • Singapore Immunology Network, A(∗)STAR, Singapore, Singapore; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore.
  • Singapore Immunology Network, A(∗)STAR, Singapore, Singapore; Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore; Institut National de la Sante et de la Recherche Medic…

Förderung

  • Intramural NIH HHS

Zitieren

APA

Ramirez-Valdez, R. A., Baharom, F., Khalilnezhad, A., Fussell, S. C., Hermans, D. J., Schrager, A. M., Tobin, K. K. S., Lynn, G. M., Khalilnezhad, S., Ginhoux, F., Van den Eynde, B. J., Leung, C. S. K., Ishizuka, A. S., & Seder, R. A. (2023). Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression. Cell Reports, 42(6), 112599. https://doi.org/10.1016/j.celrep.2023.112599

Vancouver

Ramirez-Valdez RA, Baharom F, Khalilnezhad A, Fussell SC, Hermans DJ, Schrager AM, et al. Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression. Cell Reports. 2023;42(6):112599. doi:10.1016/j.celrep.2023.112599

BibTeX
@article{RamirezValdez2023,
  author = {Ramirez-Valdez, Ramiro A and Baharom, Faezzah and Khalilnezhad, Ahad and Fussell, Sloane C and Hermans, Dalton J and Schrager, Alexander M and Tobin, Kennedy K S and Lynn, Geoffrey M and Khalilnezhad, Shabnam and Ginhoux, Florent and Van den Eynde, Benoit J and Leung, Carol Sze Ki and Ishizuka, Andrew S and Seder, Robert A},
  title = {Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {6},
  pages = {112599},
  doi = {10.1016/j.celrep.2023.112599}
}
Kostenlos starten →